multiple myeloma
The single-cell omics company recently awarded $100,000 in grants funding research on its platform and published on its use for characterizing CAR-T cells.
Natera Q1 Revenues Grow 62 Percent
The company reported $152.3 million in total revenues for the quarter and said the number of tests it processed rose 48 percent from the prior-year quarter.
Genome Sequencing Identifies Myeloma Precursor Disease With High Progression Risk
Investigators flagged a set of myeloma-defining genomic events that marked precursor conditions that were prone to morph into multiple myeloma.
Multiple Myeloma Therapy Targets, Resistance Pathways Identified With Single-Cell Sequencing
The researchers found new molecular pathways of resistance, including hypoxia tolerance, protein folding, and mitochondria respiration.
MMRF, Dana Farber Partner on Search for Biomarkers Linked to Smoldering Multiple Myeloma Progression
By identifying these biomarkers, the partners hope to better predict which SMM patients will progress to multiple myeloma and ultimately develop new treatments.